Data Archives - Page 30 of 108

How technology is revolutionizing the way patients are diagnosed and treated

August 2021, Data, Digital Biomarkers, Health Technology, Healthcare Communications Agencies, Issue Archives, Marketing & Advertising, Med Ad News, Patients, Special Features, Wearables

The World Health Organization defines health technology as “the application of organized knowledge and skills in the form of devices, medicines, vaccines, procedures, and systems developed to solve a health problem and improve quality of lives.” While that’s true, it’s a pretty broad statement. In an era when we’re seeing rapid technological shifts in the way people measure, monitor, and think about their health, it’s worth focusing any discussion of health technology to a few key areas that best highlight some of the more exciting – and challenging – aspects of health technology development at this point in 2021.

August 14, 2021/by Andrew Humphreys

Atea’s Experimental Antiviral Shows More Promise in Preventing COVID-19

Antivirals, Business, Clinical Trials, Coronavirus Disease 2019 (COVID-19), Interim Data, Partnerships, R&D, RNA Polymerase

An antiviral treatment under development by Atea Pharmaceuticals is showing promise against Covid-19.

August 13, 2021/by Andrew Humphreys

U.S. FDA declines to approve Sesen Bio’s bladder cancer treatment, shares plunge

Analysis, Approval Rejection, Bladder Cancer, Business, Clinical Data, European Medicines Agency, Fast Track Designation, Shares

The U.S. drug regulator declined to approve Sesen Bio Inc.’s lead therapy candidate for a type of bladder cancer, the company said on Aug. 13, sending its shares down more than 80 percent.

August 13, 2021/by Andrew Humphreys

FDA Set to Greenlight Boosters for Some Vulnerable Patients

BioSpace, BNT162b2 (Pfizer and BioNTech), CDC, CNN, COVID-19 booster shots, Covid-19 Data, COVID-19 Vaccines, FDA, Israel, Johns Hopkins Universit, mRNA-1273/Moderna COVID-19 Vaccine (Moderna)

The U.S. Food and Drug Administration is expected to announce that the regulatory agency is authorizing the use of a booster shot for the Pfizer-BioNTech and Moderna mRNA COVID-19 vaccines in some immunocompromised patients.

August 12, 2021/by Andrew Humphreys

Positive Topline Results for Enhertu Study

Antibody-Drug Conjugates (ADCs), AstraZeneca, Blockbusters, Chemotherapy, Clinical Trials, Data Monitoring Committee (DMC), Metastatic Breast Cancer, Monoclonal Antibodies, R&D, Taxanes, Therapeutics, Topline Data

Daiichi Sankyo and AstraZeneca reported positive topline data from their head-to-head DESTINY-Breast-03 Phase III trial for Enhertu versus trastuzumab emtansine (T-DM1) in patients with HER2 positive metastatic breast cancer.

August 9, 2021/by BioSpace

Novavax again delays seeking U.S. approval for COVID-19 vaccine

Clinical Data, Clinical Trials, COVID-19 booster shots, COVID-19 Vaccines, India, Indonesia, Middle-Income Countries, Novavax, Philippines, R&D, United States

Novavax Inc. on Aug. 5 again delayed the company’s timeline for seeking U.S. authorization for its two-dose Covid-19 vaccine, but expects to become a major distributor to lower and middle-income countries this year.

August 5, 2021/by Andrew Humphreys

U.S. COVID-19 cases hit six-month high, Florida grapples with surge

Alabama, Arkansas, COVID-19 cases, Covid-19 Variants, Delta Variant (B.1.617.2; India), Florida, Hospitalized COVID-19 Patients, Louisiana, Mississippi, Missouri, Reuters Data, Texas

The number of new Covid-19 cases climbed to a six-month high in the United States, with more than 100,000 infections reported on Aug. 5 as the Delta variant ravages Florida and other states with lower vaccination rates.

August 5, 2021/by Andrew Humphreys

Moderna’s COVID-19 shot maintains high efficacy through 6 months

BioNTech, Business, Clinical Trials, COVID-19 Antibodies, COVID-19 booster shots, COVID-19 shots, Efficacy Data, Moderna, mRNA-1273/Moderna COVID-19 Vaccine (Moderna), Pfizer, R&D, Shares

Moderna Inc. said on Aug. 5 the company’s Covid-19 vaccine was about 93% effective through six months after the second dose, showing hardly any change from the 94% efficacy reported in the original clinical trial.

August 5, 2021/by Reuters Health

Positive Phase III Results for First-Ever Single-Dose Chikungunya Vaccine

Chikungunya virus, Clinical Trials, Data Safety Monitoring Board (DSMB), FDA, Immunogenicity Data, Mosquito-Borne Infections, Neutralizing Antibodies, R&D, Topline Data

French specialty vaccine maker Valneva shared positive topline results from ongoing trials for a potential single-shot vaccine against chikungunya.

August 5, 2021/by Andrew Humphreys

Pfizer’s Ritlecitinib Stops Alopecia Areata In Its Tracks

Alopecia, Autoimmune Diseases, Clinical Trials, Efficacy Data, Hair Loss, Pfizer, Primary Endpoints, R&D

Global pharmaceutical giant Pfizer Inc. announced that the company’s trial on a potential treatment for alopecia areata achieved the study’s primary efficacy endpoint.

August 4, 2021/by Andrew Humphreys